Balance Sheet Data
Myriad Genetics, Inc. (MYGN)
$22.81
-0.50 (-2.15%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 180.60 | 136.90 | 217.80 | 339.80 | 114.90 | 184.59 | 180.49 | 176.48 | 172.56 | 168.73 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 102.10 | 138.60 | 71 | 91.30 | 101.60 | 90.96 | 88.94 | 86.97 | 85.03 | 83.15 |
| Account Receivables (%) | ||||||||||
| Inventories | 34.30 | 31.40 | 29.10 | 15.30 | 20.10 | 23.61 | 23.08 | 22.57 | 22.07 | 21.58 |
| Inventories (%) | ||||||||||
| Accounts Payable | 26 | 33.30 | 21.70 | 29.60 | 28.80 | 25.39 | 24.83 | 24.27 | 23.73 | 23.21 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -8.40 | -8.60 | -10.20 | -18 | -45.30 | -17.18 | -16.80 | -16.42 | -16.06 | -15.70 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.